Within the intricate immune microenvironment of lung cancer, characterized by a delicate balance of pro-inflammatory and immunosuppressive signals, the cGAS-STING pathway emerges as a central orchestrator governing the dynamic interplay between innate and adaptive immunity. Here, STING1 is linked to lung cancer.